Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial
Kirsten E. Lyke(University of Maryland, Baltimore), Robert Edelman(University of Maryland, Baltimore), Michael K. McCracken(Walter Reed Army Institute of Research), Sudhaunshu Joshi(University of Maryland, Baltimore), Kathleen Strauss(University of Maryland, Baltimore), Gregory D. Gromowski(Walter Reed Army Institute of Research), Hernando Gutiérrez-Barbosa(University of Maryland, Baltimore), Heather Friberg(Walter Reed Army Institute of Research), Rekha R. Rapaka(University of Maryland, Baltimore), Rafael A. De La Barrera(Walter Reed Army Institute of Research), Richard G. Jarman(Walter Reed Army Institute of Research), Adam T. Waickman(SUNY Upstate Medical University), Paula J. Bernal(University of Maryland, Baltimore), Michael Koren(Walter Reed Army Institute of Research), Biraj Shrestha(University of Maryland, Baltimore), Joel V. Chua(University of Maryland, Baltimore), Christopher Culbertson(University of Maryland, Baltimore), Jeffrey R. Currier(Walter Reed Army Institute of Research)
Cited by 24
Related Papers
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
|Gastroenterology|2021|177
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
|Nature Medicine|2020|88
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
|Nature Medicine|2023|56
A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults
|The Journal of Infectious Diseases|2020|46